Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ACOM vs BWAY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BWAY Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

BWAY Overall Winner 6-Pillar Tally: ACOM 0 – 5 BWAY (1 Tie) Matrix Metrics: ACOM 3 – 7 BWAY

As of Nov 20, 2026, Brainsway Ltd. (BWAY) is the stronger overall head-to-head candidate over ACOM (ACOM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACOM carries a Unified Composite Score of 53.3/100 (HOLD) at $21.74 (N/M Forward P/E, N/A operating margin), whereas BWAY carries 31.8/100 (SELL) at $8.48 (17.0x Forward P/E, 12.5% operating margin).

  • Composite vs. Pillar Nuance: While ACOM currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. BWAY 31.8/100 SELL), BWAY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (12.5% vs. N/A operating margin) and revenue trajectory (+35.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: ACOM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile BWAY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ACOM vs BWAY
ACOM US Equity
ACOM
Institutional Equity
$21.74
-0.54% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.15β · 18% Vol
Unified Composite Score
53.3 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 65.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 25
RSI-14: 24.6 · SMA20: $23.11 · SMA50: $23.83
BWAY NASDAQ Head-to-Head Winner
Brainsway Ltd. American Depositary Shares
Surgical & Medical Instruments & Apparatus
$8.48
-2.86% 1D
Market Cap $351.4M
TTM Revenue $108M
Forward P/E 17.0x
Beta / 30D Vol 1.84β · 66% Vol
Unified Composite Score
31.8 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -12.0%), weak momentum, RSI 28
RSI-14: 27.7 · SMA20: $10.57 · SMA50: $11.74

6-Pillar Scorecard Institutional Category Breakdown (ACOM 0 – 5 BWAY)

Columns: Metric · ACOM · BWAY
1. Valuation Multiples BWAY
Forward P/E N/M 17.0x
Trailing P/E N/M 36.4x
PEG Ratio N/M N/M
EV / Revenue N/M 3.3x
2. Growth & Scale BWAY
Revenue Growth (YoY) N/A +35.4%
Earnings Growth (YoY) N/A +59.8%
TTM Revenue (USD) N/A $108M
Market Cap N/A $351.4M
3. Profitability & Quality BWAY
Gross Margin N/A 75.3%
Operating Margin N/A 12.5%
Net Profit Margin N/A 15.6%
Return on Equity (ROE) N/A 12.8%
4. Balance Sheet & Cash Flow BWAY
Cash Generation (TTM) N/A $15M EBITDA
Cash Flow Margin N/A 14.0% EBITDA Mgn
Net Cash / Leverage N/A ROE $1.97 Book/Sh · 12.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 111.0% (77th %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BWAY
OpEx & R&D Intensity N/A 62.8% of Rev ($68M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ACOM (3) vs BWAY (7)
Institutional Metric ACOM BWAY Criterion Row Edge
Market Capitalization
Scale
N/A $351.4M Larger Scale BWAY
Trailing P/E Ratio
Valuation
N/M 36.4x Lower Multiple BWAY
Forward P/E Ratio
Valuation
N/M 17.0x Lower Multiple BWAY
Revenue Growth (YoY)
Growth
N/A +35.4% Higher Growth BWAY
Operating Margin (TTM)
Profitability
N/A 12.5% Higher Margin BWAY
Net Profit Margin
Profitability
N/A 15.6% Higher Margin BWAY
Return on Equity (ROE)
Capital Efficiency
N/A 12.8% Higher ROE BWAY
52-Week Range Position
Momentum
44% ($19–$25) 0% ($8–$27) Stronger Trend ACOM
Beta / 30D Volatility
Risk Regime
-0.15β · 18% Vol 1.84β · 66% Vol Lower Realized Risk ACOM
Unified Institutional Score
Composite Signal
53.3 / 100 (HOLD) 31.8 / 100 (SELL) Higher Composite ACOM
Trailing 12M Revenue (USD)
Operating Scale
N/A $108M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 75.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 3.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $15M EBITDA ($1.97 Book/Sh · 12.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACOM +14.48 pp
ACOM: -11.39% · BWAY: -25.87%
3M Horizon ACOM +32.67 pp
ACOM: -7.57% · BWAY: -40.24%
6M Horizon ACOM +50.53 pp
ACOM: +9.38% · BWAY: -41.15%
1Y Horizon ACOM +50.53 pp
ACOM: +9.38% · BWAY: -41.15%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACOM vs BWAY. Trailing 12-month operating profitability (ACOM N/A vs BWAY 12.5%) and valuation multiples (ACOM N/M vs BWAY 17.0x Forward P/E) are benchmarked directly in Pillar 4 below.

ACOM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
BWAY ADR TTM Benchmark FX-Normalized USD
TTM Revenue$108M
Gross Margin75.3%
Op. Margin12.5%
ROE / Fwd P/E12.8% · 17.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ACOM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACOM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BWAY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 111.0%
IV Percentile 77th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BWAY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ACOM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BWAY Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $351.4M market capitalization and 12.5% operating margin.
OpEx & R&D Reinvestment 62.8% of Rev ($68M)
90D Engineering Disclosures 0 Published

Investor FAQ ACOM vs BWAY Key Questions & Quantitative Answers

As of Nov 20, 2026, Brainsway Ltd. (BWAY) is the stronger overall head-to-head candidate over ACOM (ACOM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ACOM carries a Unified Composite Score of 53.3/100 (HOLD) at $21.74 (N/M Forward P/E, N/A operating margin), whereas BWAY carries 31.8/100 (SELL) at $8.48 (17.0x Forward P/E, 12.5% operating margin). Composite vs. Pillar Nuance: While ACOM currently prints a higher short-term Unified Composite Score (53.3/100 HOLD vs. BWAY 31.8/100 SELL), BWAY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (12.5% vs. N/A operating margin) and revenue trajectory (+35.4% vs. N/A YoY). Technical & Structure Timing Caution: ACOM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.6); meanwhile BWAY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BWAY leads the Growth & Scale pillar: ACOM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BWAY at +35.4% YoY revenue growth and +59.8% YoY earnings growth on $108M TTM revenue (75.3% gross margin, 12.5% operating margin). On trailing 12-month operating scale, ACOM generates N/A in USD-normalized revenue versus $108M for BWAY. In operating R&D and SG&A reinvestment, ACOM deploys N/A (0 90-day corporate R&D disclosures) versus 62.8% of Rev ($68M) (0 disclosures) for BWAY.

BWAY screens cheaper on headline valuation multiples. ACOM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BWAY trades at 17.0x Forward P/E, 36.4x Trailing P/E, N/M PEG, and 3.3x EV/Revenue (14.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACOM (N/A ROE) versus BWAY (12.8% ROE) capital efficiency.

In options market volatility and institutional positioning, ACOM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.15β · 18% Vol realized risk). By comparison, BWAY carries 111.0% implied volatility (77th %ile, Elevated (60th–80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.84β · 66% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.